ABBOTT LABORATORIES Funds and ETFs Abbott Laboratories
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.6 USD | -1.12% |
|
-2.61% | -6.06% |
| 09/05 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
| 08/05 | Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing | MT |
ETFs positioned on Abbott Laboratories
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.18% | 17 M€ | +6.46% | - | |
| 5.19% | 2 M€ | -.--% | ||
| 3.00% | 2 M€ | -.--% | - | |
| 2.34% | 9 M€ | -.--% | - | |
| 2.02% | 1 M€ | +16.32% | ||
| 1.88% | 2 M€ | +21.73% | - | |
| 1.80% | 5 M€ | -72.95% | - | |
| 1.76% | 1 M€ | +2.21% | - | |
| 1.30% | 37 M€ | -.--% | ||
| 1.20% | 2 M€ | +9.27% | ||
| 1.12% | 8 M€ | +4.88% | ||
| 1.00% | 204 M€ | +10.54% | ||
| 0.94% | 330 M€ | -.--% | ||
| 0.77% | 265 M€ | +5.17% | - | |
| 0.76% | 1,174 M€ | +23.54% | ||
| 0.76% | 273 M€ | -.--% | ||
| 0.76% | 655 M€ | -.--% | - | |
| 0.76% | 104 M€ | +8.89% | ||
| 0.69% | 26 M€ | +19.98% | - | |
| 0.67% | 8 M€ | +5.48% | - | |
| 0.66% | 1,848 M€ | +18.39% | - | |
| 0.66% | 559 M€ | +14.30% | ||
| 0.65% | 1 M€ | +0.04% | ||
| 0.60% | 744 M€ | +8.55% | ||
| 0.60% | 8 M€ | +5.74% | - | |
| 0.60% | 6 M€ | +17.98% | - | |
| 0.60% | 121 M€ | +6.82% | - |
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:
- diagnostic systems and instruments (39.1%);
- vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.;
- nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products;
- medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;
- other (15.9%).
Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Calendar
18/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8
USD
Average target price
126.1
USD
Spread / Average Target
+20.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.06% | 18TCr | |
| +1.63% | 11TCr | |
| -3.88% | 6.85TCr | |
| +0.56% | 4.97TCr | |
| +7.65% | 4.45TCr | |
| +2.33% | 4.07TCr | |
| +22.34% | 3.12TCr | |
| +0.99% | 2.61TCr | |
| +15.30% | 2.53TCr | |
| -1.85% | 2.46TCr |
- Stock Market
- Equities
- ABT Stock
- Funds and ETFs Abbott Laboratories